Alopecia areatahttps://en.wikipedia.org/wiki/Alopecia_areata
Alopecia areata ndi chikhalidwe cha komweko komwe tsitsi limatayika m'thupi. Nthawi zambiri, kumapangitsa kuti pamutu pakhale madontho ochepa okwana dazi. Matendawa angayambe chifukwa cha kupsinjika maganizo.

Alopecia areata amakhulupirira kuti ndi matenda a autoimmune okhudzana ndi chitetezo chamthupi cha follicles ya tsitsi. Zomwe zimapangidwira zimaphatikizira kulephera kwa thupi kuzindikira ma cell ake omwe, ndikuwonongeka kwatsitsi ndi chitetezo chamthupi.

Chithandizo ― OTC Mankhwala
Anthu ena omwe ali ndi alopecia areata pang'ono amachira mkati mwa chaka popanda chithandizo. Komabe, anthu ambiri amakumana ndi zobwerezabwereza pamalo osasintha pamutu.
#Hydrocortisone cream

Machiritso
Majekeseni a intralesional steroid ndiwo mankhwala othandiza kwambiri. Immunotherapy ikhoza kuyesedwa ngati madera akuluakulu a scalp akhudzidwa.
#Triamcinolone intralesional injection
#DPCP immunotherapy
☆ Muzotsatira za 2022 Stiftung Warentest zochokera ku Germany, kukhutitsidwa kwa ogula ndi ModelDerm kunali kotsika pang'ono kusiyana ndi kuyankhulana kwa telemedicine komwe kulipiridwa.
  • Alopecia areata ikuwoneka kumbuyo kwa scalp. Nthawi zambiri, zimawonekera mwadzidzidzi ndi malo osalala komanso kukula kwa 2-3 cm.
  • Kutayika tsitsi kozungulira kozungulira
References Alopecia areata 28300084 
NIH
Alopecia areata ndi mkhalidwe womwe chitetezo chanu cha mthupi chimaukira ma follicles atsitsi, zomwe zimapangitsa kuti tsitsi lanu likhale kwakanthawi popanda zilonda. Zitha kuwoneka ngati zigamba za tsitsi kapena kukhudza khungu lanu lonse kapena thupi lanu, zomwe zimakhudza pafupifupi 2% ya anthu nthawi zina pamoyo wawo. Mlandu waukulu ukuwoneka kuti ndi kuwonongeka kwa chitetezo chachilengedwe kuzungulira tsitsi.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
 Alopecia Areata: An Updated Review for 2023 37340563 
NIH
Alopecia areata ndi mkhalidwe womwe chitetezo chamthupi chimalimbana ndi ma follicles atsitsi, kuchititsa tsitsi kumutu ndi mbali zina zaubweya zathupi. Zimakhudza pafupifupi 2% ya anthu padziko lonse lapansi. Ngakhale zikhoza kuchitika pa msinkhu uliwonse, ndizofala kwambiri mwa ana kusiyana ndi akuluakulu (1. 92% vs. 1. 47%) . Azimayi, makamaka omwe ali ndi zaka zoposa 50, amakumana ndi izi kuposa amuna. Kubaya jekeseni wa corticosteroids m'madera omwe akhudzidwawo kwawonetsa zotsatira zabwino kuposa kuwagwiritsa ntchito pamutu.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.